Hepatitis B Surface Antibody
Hepatitis B Surface Antibody
Categories
- Health Assessment and Safety
- Serology/infectious Disease
General Information
| Name | Information |
|---|---|
| Code: | T144 |
| Matrix: | Serum / Plasma |
| Application: | Insurance Risk Assessment, Wellness |
| Turnaround Time: | Daily |
| Analytical - Method: | sandwich immunoassay using direct, chemiluminometric technology |
| Reportable - Test Results Type: | Qualitative |
| Units - Conventional: | mIU/Ml |
Specimen Information
| Name | Information |
|---|---|
| Minimum Volume: | 100 μL |
| Preferred Volume: | 500µL |
| Rejection Criteria: | M102 QNS Quantity not sufficient for analysis. M268 NSA Not suitable for analysis. Incorrect specimen type submitted. M321 NSA Not suitable for analysis. Sample integrity questionable. M376 NSA Not suitable for analysis. Grossly Bloody Specimen. M498 TNP Test Not performed due to analyte degradation. M757 QNS Due to laboratory accident. M758 QNS Specimen leaked in transit M759 QNS Specimen tube broke in transit. |
| Collection Instructions: | See “Blood Collection” |
| Collection Patient Preparation: | NA |
| Container: | Serum and plasma (EDTA, lithium-heparinized, or sodium heparinized) are the recommended sample types for this assay. • Handle all samples as if capable of transmitting disease. • Samples are processed by centrifugation, typically followed by physical separation of the serum or plasma from the red cells. The centrifugation step may occur up to 24 hours post draw. |